Tag: EGFR Resisters
Disrupting the Paradigm: Partnering With Oncogene-Focused Patient Groups to Propel Research
By Amy C. Moore, PhD, and Upal Basu Roy, PhD, MPH
Posted: April 16, 2020
Genomic alterations drive more than 60% of adenocarcinoma cases of NSCLC.1...
Letter to the Editor: Patient-Driven Research
By Jill Feldman, EGFR Resisters Co-Founder
Posted: December 11, 2019
I was so glad to see the article by Dr. Amy Moore on PDX models in the...
